What does INTIBIO do?

INTIBIO is registered with the CBE as active in: Vervaardiging van geneesmiddelen. Private Limited, started on 12 November 2019, 1 establishment.

What is the address of INTIBIO?

The registered office of INTIBIO is located at Berkenbroekstraat 1, 3960 Bree.

Is INTIBIO still active?

Yes. According to the CBE (29 October 2026) INTIBIO is active, legal situation “Normale toestand”, started on 12 November 2019.

Is INTIBIO registered on Peppol?

Yes, INTIBIO is registered on the Peppol network with ID 0208:0737613932.

What is the enterprise number of INTIBIO?

The enterprise number of INTIBIO is BE0737613932.

When was INTIBIO founded?

INTIBIO was founded on 12 November 2019.

Who are the directors of INTIBIO?

According to the 2025 annual accounts, the directors of INTIBIO are: Virtus Bonarum Cellarum, Suls Equine Veterinary Services.

Is INTIBIO a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 November 2019; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did INTIBIO make in 2025?

INTIBIO posted a profit after taxes of € 91,024 in financial year 2025.

What is the revenue of INTIBIO?

As a small company, INTIBIO is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 278,015.

Does INTIBIO have a website?

Yes, INTIBIO has a website at vianovaequine.com.

INTIBIO (Private Limited) - Bree - BE0737613932

Dossier INTIBIO, printed on 29 October 2026 from databakkes.be/en/0737613932/intibio. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 57 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

INTIBIO from Bree, company number BE0737613932, closed financial year 2025 with a result of € 91,024 after tax. For that financial year INTIBIO recorded a gross margin of € 278,015 and equity of € 145,987. Compared with financial year 2024, the result moved from € 49,386 to € 91,024. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Growing

€ 145,987

▲ 166% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 91,024

▲ 84% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 29,557

▲ 53% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 142,987.

People and assets in 2025

Wage cost

€ 129,623

▲ 130% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 26,796

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 127,491

▲ 219% vs 2024

€ 31,070 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 48,652

▼ 44% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 13,139

▼ 55% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 42,660 Gross margin 2022: € 42,660 First fiscal year in the series	€ 27,507 Gross margin 2023: € 27,507 ▼ 36% vs 2022 (€ 42,660) Unfavourable step	€ 135,600 Gross margin 2024: € 135,600 ▲ € 108,093 vs 2023 (€ 27,507) Favourable step	€ 278,015 Gross margin 2025: € 278,015 ▲ 105% vs 2024 (€ 135,600) Favourable step	▲ 105%
Profit after taxes	€ 29,112 Profit after taxes 2022: € 29,112 First fiscal year in the series	€ 10,170 Profit after taxes 2023: € 10,170 ▼ 65% vs 2022 (€ 29,112) Unfavourable step	€ 49,386 Profit after taxes 2024: € 49,386 ▲ € 39,217 vs 2023 (€ 10,170) Favourable step	€ 91,024 Profit after taxes 2025: € 91,024 ▲ 84% vs 2024 (€ 49,386) Favourable step	▲ 84%
Equity	€ 5,577 Equity 2022: € 5,577 First fiscal year in the series	€ 5,577 Equity 2023: € 5,577 Unchanged (€ 5,577) Unchanged	€ 54,963 Equity 2024: € 54,963 ▲ € 49,386 vs 2023 (€ 5,577) Favourable step	€ 145,987 Equity 2025: € 145,987 ▲ 166% vs 2024 (€ 54,963) Favourable step	▲ 166%
Total debts	€ 91,235 Total debts 2022: € 91,235 First fiscal year in the series	€ 169,603 Total debts 2023: € 169,603 ▲ 86% vs 2022 (€ 91,235) Unfavourable step	€ 316,646 Total debts 2024: € 316,646 ▲ 87% vs 2023 (€ 169,603) Unfavourable step	€ 261,790 Total debts 2025: € 261,790 ▼ 17% vs 2024 (€ 316,646) Favourable step	▼ 17%
Cash	€ 50,962 Cash 2022: € 50,962 First fiscal year in the series	€ 23,748 Cash 2023: € 23,748 ▼ 53% vs 2022 (€ 50,962) Unfavourable step	€ 19,367 Cash 2024: € 19,367 ▼ 18% vs 2023 (€ 23,748) Unfavourable step	€ 29,557 Cash 2025: € 29,557 ▲ 53% vs 2024 (€ 19,367) Favourable step	▲ 53%
Retained profit	€ 2,577 Retained profit 2022: € 2,577 First fiscal year in the series	€ 2,577 Retained profit 2023: € 2,577 Unchanged (€ 2,577) Unchanged	€ 51,963 Retained profit 2024: € 51,963 ▲ € 49,386 vs 2023 (€ 2,577) Favourable step	€ 142,987 Retained profit 2025: € 142,987 ▲ 175% vs 2024 (€ 51,963) Favourable step	▲ 175%
Dividend	€ 70,000 Dividend 2022: € 70,000 First fiscal year in the series	€ 10,170 Dividend 2023: € 10,170 ▼ 85% vs 2022 (€ 70,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 10,170) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 33,691 Bank debt 2023: € 33,691 Unchanged (€ 0) Unfavourable step	€ 40,003 Bank debt 2024: € 40,003 ▲ 19% vs 2023 (€ 33,691) Unfavourable step	€ 127,491 Bank debt 2025: € 127,491 ▲ 219% vs 2024 (€ 40,003) Unfavourable step	▲ 219%
Balance sheet total	€ 96,812 Balance sheet total 2022: € 96,812 First fiscal year in the series	€ 175,181 Balance sheet total 2023: € 175,181 ▲ 81% vs 2022 (€ 96,812) Unchanged	€ 371,609 Balance sheet total 2024: € 371,609 ▲ 112% vs 2023 (€ 175,181) Unchanged	€ 407,778 Balance sheet total 2025: € 407,778 ▲ 10% vs 2024 (€ 371,609) Unchanged	▲ 10%

Key figures of INTIBIO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to INTIBIO?

What happened at INTIBIO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Virtus Bonarum Cellarum stepped down as director. NBB
2030 Suls Equine Veterinary Services stepped down as director. NBB
Jul 22, 2026 New annual accounts for financial year 2025: profit of € 91,024 (▲ 84% vs 2024). Source: NBB ↗
2024 Virtus Bonarum Cellarum became a director. NBB
2024 Suls Equine Veterinary Services became a director. NBB
Nov 12, 2019 New establishment in Bree. KBO
Nov 12, 2019 Start of the company according to the CBE. KBO

In short

From € 29,112 profit in 2022 to € 91,024 profit in 2025.

Paid € 62,411 in corporate taxes since 2022.

Best year ever: 2025, with € 91,024 profit.

Paid out € 80,170 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

IXTLILTON 26%

Cedric Bocqué 22%

The stake of IXTLILTON, Cedric Bocqué comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

INTIBIO

The shares are held by IXTLILTON (26%) and Cedric Bocqué (22%).

Directors

According to the 2025 annual accounts

Virtus Bonarum Cellarum

Director · represented by Jan Spaas

Also active at: Berkenbroek, AnimAb

since 2024 · until 2030

Suls Equine Veterinary Services

Director · represented by Marc Suls

since 2024 · until 2030

Shareholders

IXTLILTON

26%

Cedric Bocqué

22%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Berkenbroekstraat 1

3960 Bree

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

Berkenbroek same network

€ 155,206 gross margin · 2025

MOCLERO

€ 67,447 gross margin · 2025

Virtus Bonarum Cellarum same network

€ 119,689 gross margin · 2025

VETERINARY INNOVATION ALLIANCE

€ 1.1 million gross margin · 2025

Via Nova Equine Services

€ 614,855 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS vianovaequine.com

Technologies

ApacheElementorFont AwesomePHPVimeoWPMLWordPressYoast SEOjQueryjQuery UIlazysizes

Hosting & Email

Email provider

Self-hosted

Hosting

DIGITALOCEAN-ASN - DigitalOcean, LLC, US

Domain

vianovaequine.com

Registered

2017-11-06

Registrar

Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA

Expires

2026-11-06

Website info

HTTPS Ja

Languages NL

Features

Webshop Jobs Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number

0737.613.932

VAT number

BE 0737.613.932

Registered office

Berkenbroekstraat 1, 3960 Bree

Names & denominations

INTIBIO

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

12 November 2019

Peppol

Active · Active since 21 Oct 2026

Contact

vianovaequine.com

Activities · NACE

Vervaardiging van geneesmiddelen

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Vervaardiging van andere voedingsmiddelen, neg

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

INTIBIO

Warning lights

Financials

What happened to INTIBIO?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Details

Frequently asked questions